Cargando…

Surgery for early-stage small cell lung cancer: is it worth it?

Detalles Bibliográficos
Autores principales:	Vyfhuis, Melissa A. L., Mohindra, Pranshu, Simone, Charles B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794444/ https://www.ncbi.nlm.nih.gov/pubmed/35118253 http://dx.doi.org/10.21037/med.2019.06.01

Ejemplares similares

Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020)

Advances in proton therapy in lung cancer
por: Vyfhuis, Melissa A.L., et al.
Publicado: (2018)

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
por: Vyfhuis, Melissa A.L., et al.
Publicado: (2017)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

Robotic surgery in early-stage endometrial cancer
por: Corrado, Giacomo, et al.
Publicado: (2019)

Lung biopsy in ARDS: is it worth the risk?
por: Malhotra, Atul, et al.
Publicado: (2006)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Non-in situ heart-lung transplantation: doing less may prove to be worth it
por: Thomas, Jason O. A., et al.
Publicado: (2021)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Radical segmentectomy as a potential alternative surgical treatment with curative intent in early-stage non-small cell lung cancer
por: Koike, Terumoto, et al.
Publicado: (2020)

OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
por: Hayes, Daniel F
Publicado: (2013)

Simultaneous appendage ligation and atrial ablation – is it worth the risk?
por: Garg, Jalaj, et al.
Publicado: (2021)

Commentary: Is the juice worth the squeeze?
por: Demmy, Todd L.
Publicado: (2020)

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
por: Shepherd, Annemarie F., et al.
Publicado: (2020)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Use of adjuvant EGFR tyrosine kinase inhibitors in early stage EGFR-mutant non-small cell lung cancer: is the evidence strong enough?
por: Lemmon, Christopher, et al.
Publicado: (2020)

Thoracoscopic anatomical segmentectomies for early-stage lung cancer: the coming challenge
por: Gossot, Dominique, et al.
Publicado: (2020)

The cost-effectiveness challenge: is it worth it?
por: Knapp, Martin
Publicado: (2015)

Commentary: Is the juice worth the squeeze?
por: Lantz, Gurion, et al.
Publicado: (2021)

In search of goldilocks: the quest to optimize combination drug strategies for the management of advanced stage non-small-cell lung cancer
por: Bindal, Poorva, et al.
Publicado: (2020)

Global longitudinal strain in cardio-oncology: worth our trouble or more trouble than it’s worth?
por: Teske, Arco J.
Publicado: (2023)

Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer
por: Shapiro, Charles L.
Publicado: (2020)

Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules
por: Frattini, Milo, et al.
Publicado: (2021)

A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy
por: Yuan, Xun, et al.
Publicado: (2021)

Is sodium chloride worth its salt?
por: McIntosh, Euan, et al.
Publicado: (2013)

“TEG” talks: technology worth spreading?
por: Selby, Rita
Publicado: (2023)

Commentary: Ectasia after keratorefractive surgery: An ounce of prevention is worth a pound of cure
por: Narang, Purvasha
Publicado: (2020)

KEYNOTE-407: changing the way we treat stage IV squamous non-small cell lung cancer
por: Pacheco, Jose M.
Publicado: (2020)

Endoscopic surgery: One picture worth thousand words
por: Wattiez, Arnoud
Publicado: (2017)

The Worthing Experiment
Publicado: (1958)

Worth Attention
Publicado: (1885)

Antimicrobial catheters in the ICU: is the juice worth the squeeze?
por: Safdar, Nasia
Publicado: (2009)

A Picture Is Worth a Thousand Words
por: Turner, Jerrold R.
Publicado: (2016)

A Budget in Hand is Worth Two in the Bush
Publicado: (2000)

Pharmaceutical Manufacturer Prescription Assistance Programs: Are They Worth It?
por: Chen, Judy T., et al.
Publicado: (2007)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

Thoracoscopic anatomical segmentectomy for early-stage non-small cell lung cancer: minimally invasive surgery involving various approaches
por: Kato, Hirohisa
Publicado: (2023)

Parallel Import: Is It Worth?
por: Peiravian, Farzad
Publicado: (2014)

Something Worth Fighting for
Publicado: (1883)

Cannot write session to /tmp/vufind_sessions/sess_ppam7ddtgrn9ss789rbjt86voi